Prevalence and associated risk factors of mortality among COVID-19 patients: a meta-analysis

FM Noor, MM Islam - Journal of community health, 2020 - Springer
Objectives The main aim of this study was to find the prevalence of mortality among
hospitalized COVID-19 infected patients and associated risk factors for death. Methods …

Outcomes of patients with coronavirus disease 2019 receiving organ support therapies: the international viral infection and respiratory illness universal study registry

JP Domecq, A Lal, CR Sheldrick, VK Kumar… - Critical care …, 2021 - journals.lww.com
OBJECTIVES: To describe the outcomes of hospitalized patients in a multicenter,
international coronavirus disease 2019 registry. DESIGN: Cross-sectional observational …

SARS-CoV-2 leads to a small vessel endotheliitis in the heart

U Maccio, AS Zinkernagel, SM Shambat, X Zeng… - …, 2021 - thelancet.com
Abstract Background SARS-CoV-2 infection (COVID-19 disease) can induce systemic
vascular involvement contributing to morbidity and mortality. SARS-CoV-2 targets epithelial …

Diagnostic SARS-CoV-2 cycle threshold value predicts disease severity, survival, and six-month sequelae in COVID-19 symptomatic patients

M Trunfio, F Venuti, F Alladio, BM Longo, E Burdino… - Viruses, 2021 - mdpi.com
To date, there is no severe acute respiratory syndrome coronavirus 2-(SARS-CoV-2)-
specific prognostic biomarker available. We assessed whether SARS-CoV-2 cycle threshold …

Convalescent plasma against COVID-19: a broad-spectrum therapeutic approach for emerging infectious diseases

M Thijssen, T Devos, HS Ejtahed, S Amini-Bavil-Olyaee… - Microorganisms, 2020 - mdpi.com
In the lack of an effective vaccine and antiviral treatment, convalescent plasma (CP) has
been a promising therapeutic approach in past pandemics. Accumulating evidence in the …

[HTML][HTML] Follow-up analysis of pulmonary function, exercise capacity, radiological changes, and quality of life two months after recovery from SARS-CoV-2 pneumonia

E Strumiliene, I Zeleckiene, R Bliudzius, A Samuilis… - Medicina, 2021 - mdpi.com
Background and objective: According to the World Health Organization (WHO), more than
100 million people have already recovered from SARS-CoV-2 infection. Therefore, it is …

Acute tubulointerstitial nephritis and COVID-19

JH Ng, M Zaidan, KD Jhaveri… - Clinical Kidney …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) is an ongoing pandemic that to date has
spread to> 100 countries. Acute kidney injury is not uncommon with this disease. The most …

[HTML][HTML] Clinical and imaging features of COVID-19-associated pulmonary aspergillosis

T Fischer, Y El Baz, N Graf, S Wildermuth, S Leschka… - Diagnostics, 2022 - mdpi.com
Background: COVID-19 superinfection by Aspergillus (COVID-19-associated aspergillosis,
CAPA) is increasingly observed due to increased awareness and use of corticosteroids. The …

[HTML][HTML] Clinical outcome of hospitalized COVID-19 patients with history of atrial fibrillation

V Russo, A Silverio, F Scudiero, A D'Andrea, E Attena… - Medicina, 2022 - mdpi.com
Background and objectives: Pre-existing atrial fibrillation (AF) is a frequent comorbidity in
hospitalized patients with COVID-19; however, little is still known about its prognostic role in …

A New Hematological Prognostic Index For Covid-19 Severity

AA Hammadi, AMA Jubouri, G Ahmed, AH Hayyawi… - Medrxiv, 2021 - medrxiv.org
Background severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or Covid-19 is
a nationwide public health emergency with significant impact on human life. Objective To …